Logo image of ACTU

ACTUATE THERAPEUTICS INC (ACTU) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ACTU - US0050831009 - Common Stock

5.86 USD
+0.3 (+5.4%)
Last: 1/21/2026, 8:00:00 PM
5.86 USD
0 (0%)
After Hours: 1/21/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ACTU revenue by date.ACTU revenue by date.
N/AN/AN/AN/A
354.01%		N/A
388.33%		N/A
86.66%		N/A
57.39%		N/A
37.98%		N/A
28.91%
EBITDA
YoY % growth
ACTU ebitda by date.ACTU ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACTU ebit by date.ACTU ebit by date.
-20.207M-24.974M
-23.59%		-25.161M
-0.75%		N/A
5.05%		N/A
-21.23%		N/A
-48.28%		N/A
-8.41%		N/A
118.17%		N/A
973.92%		N/A
91.97%		N/A
49.94%		N/A
35.14%
Operating Margin
ACTU operating margin by date.ACTU operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACTU eps by date.ACTU eps by date.
N/AN/AN/AN/A
64.00%		N/A
4.62%		N/A
-34.79%		N/A
9.97%		N/A
112.15%		N/A
1,093.75%		N/A
79.06%		N/A
12.57%		N/A
19.48%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.25
24.27%		-0.26
20.31%		-0.22
27.61%		-0.24
4.12%		-0.26
-2.04%		-0.30
-16.00%		-0.34
-50.00%		-0.37
-53.19%		-0.40
-56.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.729M
12.65%		-6.375M
-0.15%		-7.14M
-19.62%		-7.65M
-39.79%		-8.415M
-46.88%		-10.2M
-60.00%		-11.475M
-60.71%		-12.75M
-66.67%		-14.025M
-66.67%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.25 -0.280.0311.68%
Q2 2025
Q2Q % growth		 -0.31 -0.320.013.52%
Q1 2025
Q2Q % growth		 -0.32 -0.31-0.01-3.43%
Q4 2024
Q2Q % growth		 -0.33 -0.30-0.03-11.56%
ACTU Yearly EPS VS EstimatesACTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ACTU Yearly Revenue VS EstimatesACTU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS9.26% 10.09% 0% 1.52%
RevenueN/A N/A N/A N/A